Where’s Menactra? No Word From Sanofi-Aventis As User Fee Date Passes
This article was originally published in The Pink Sheet Daily
Executive Summary
The estimated user fee deadline for the meningococcal conjugate vaccine was Oct. 18. FDA says the vaccine is not currently a licensed product; Sanofi-Aventis has not announced an action by the agency.